Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.

Rheumatology
David IsenbergNeil Solomons

Abstract

To compare the efficacy and safety of mycophenolate mofetil (MMF) and intravenous cyclophosphamide (IVC) as induction treatment for lupus nephritis (LN), by race, ethnicity and geographical region. A total of 370 patients with active Class III-V LN received MMF (target dose 3.0 g/day) or IVC (0.5-1.0 g/m(2)/month), plus tapered prednisone, for 24 weeks. Renal function, global disease activity, immunological complement (C3 and C4) and anti-dsDNA levels are the outcomes that were assessed in this study. MMF was not superior to IVC as induction treatment (primary objective). There were important pre-specified interactions between treatment and race (P = 0.047) and treatment and region (P = 0.069) (primary endpoint). MMF and IVC response rates were similar for Asians (53.2 vs 63.9%; P = 0.24) and Whites (56.0 vs 54.2%; P = 0.83), but differed in the combined Other and Black group (60.4 vs 38.5%; P = 0.03). Fewer patients in the Black (40 vs 53.9%; P = 0.39) and Hispanic (38.8 vs 60.9%; P = 0.011) groups responded to IVC. Latin American patients had lower response to IVC (32 vs 60.7%; P = 0.003). Baseline disease characteristics were not predictive of response. The incidence of adverse events (AEs) was similar across groups. Serious...Continue Reading

References

Feb 13, 2001·QJM : Monthly Journal of the Association of Physicians·J FontM Ingelmo
Oct 27, 2001·Lupus·G S Alarcón
Apr 18, 2002·Lupus·G S AlarcónUNKNOWN PROFILE Study Group
Jun 25, 2002·The American Journal of Medicine·Victoria A SeligmanLindsey A Criswell
Sep 19, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R Graham BarrJai Radhakrishnan
Jan 14, 2004·Kidney International·Jan J WeeningUNKNOWN Renal Pathology Society Working Group on the Classification of Lupus Nephritis
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Jan J WeeningMichio Nagata
Mar 5, 2004·The New England Journal of Medicine·Gabriel ContrerasDavid Roth
Jun 11, 2004·The New England Journal of Medicine·Chee-Seng Yee, Caroline Gordon
Feb 25, 2005·Journal of the American Society of Nephrology : JASN·Tak-Mao ChanUNKNOWN Hong Kong Nephrology Study Group
Nov 25, 2005·The New England Journal of Medicine·Ellen M GinzlerGerald B Appel
Apr 7, 2006·Kidney International·G ContrerasB Smith-Norwood
Aug 25, 2006·Kidney International·M Waldman, G B Appel
Dec 15, 2006·Journal of the American Society of Nephrology : JASN·Stephen M KorbetUNKNOWN Collaborative Study Group
Apr 17, 2009·Journal of the American Society of Nephrology : JASN·Gerald B AppelUNKNOWN Aspreva Lupus Management Study Group

❮ Previous
Next ❯

Citations

Mar 1, 2014·Clinical Rheumatology·Manuel F Ugarte-Gil, Graciela S Alarcón
Jun 3, 2014·La Presse médicale·Pamela M K LutaloDavid P D'Cruz
May 27, 2014·La Presse médicale·Zoubida Tazi Mezalek, Wafaa Bono
Apr 4, 2014·Age·Jaqueline B SchuchFabiana M de Andrade
May 18, 2011·Current Rheumatology Reports·Maria Dall'era, Eliza F Chakravarty
May 18, 2011·Current Rheumatology Reports·Katrina Shum, Anca Askanase
Mar 12, 2013·Clinical Pharmacokinetics·Azrin N Abd RahmanChristine E Staatz
Oct 6, 2011·Clinical Rheumatology·Wang-Dong XuDong-Qing Ye
Jul 2, 2011·Current Opinion in Rheumatology·Maria Dall'Era
Apr 26, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Kjell Tullus
Nov 16, 2013·Current Allergy and Asthma Reports·Adeel Zubair, Marianne Frieri
Nov 8, 2011·Clinical and Experimental Nephrology·Keiko Uchida, Kosaku Nitta
Sep 16, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Xiao LiNan Chen
Apr 24, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Desmond Y H YapTak Mao Chan
Apr 13, 2012·Arthritis Research & Therapy·David A Isenberg
Jan 11, 2013·Arthritis Research & Therapy·Aisha Lateef, Michelle Petri
May 16, 2012·Modern Rheumatology·Antonis FanouriakisDimitrios T Boumpas
Mar 25, 2015·Modern Rheumatology·Shinsuke YasudaYoshinari Takasaki
Oct 17, 2015·Clinical and Experimental Nephrology·Tasnim F ImranNeil Kothari
May 15, 2015·Expert Review of Clinical Immunology·Eleana Ntatsaki, David Isenberg
Jan 6, 2016·Nature Reviews. Rheumatology·C C Mok
Nov 20, 2015·Nature Reviews. Rheumatology·Anne Davidson
Aug 16, 2013·Autoimmunity·Enrica P BozzoloMaria Grazia Sabbadini
Aug 26, 2011·Autoimmunity·Yemil Atisha-FregosoLuis Llorente
Jun 21, 2011·The American Journal of the Medical Sciences·Hala AlshayebElvira O Gosmanova
Sep 1, 2015·Lupus Science & Medicine·Lucy CroyleEric F Morand
Nov 15, 2014·Lupus Science & Medicine·G GreloniE R Soriano
Feb 5, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael WalshDavid R W Jayne
Feb 5, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·George K Bertsias, Dimitrios T Boumpas
Jan 3, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·João Furtado, David A Isenberg
Jul 30, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hong-Na WangShan-Yan Lin
Jun 19, 2012·The Medical Clinics of North America·Ajay Kher, Vijay Kher
Jun 19, 2012·The Medical Clinics of North America·Anne V Miller, Sriya K M Ranatunga
Mar 1, 2012·Revista clínica española·G Ruiz-IrastorzaUNKNOWN Sociedad Española de Nefrología
May 14, 2011·Autoimmunity Reviews·Guillermo J Pons-EstelRicard Cervera
Mar 6, 2010·Rheumatic Diseases Clinics of North America·Robert Clancy, Ellen M Ginzler
Jul 22, 2015·Survey of Ophthalmology·Efrosini PapagiannuliAlastair K Denniston
Nov 28, 2015·Rheumatic Diseases Clinics of North America·Diane L Kamen, Eric S Zollars
Jan 13, 2012·Annals of the New York Academy of Sciences·Mindy S Lo, George C Tsokos

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Clinical Trials Mentioned

NCT00377637

Software Mentioned

SAS

Related Concepts

Related Feeds

Alstrom Syndrome

Alstrom syndrome is a rare disorder characterized by early obesity, loss of central vision, diabetes mellitus, hearing loss, and short stature. Here is the latest research.